goglides.dev
ResearchFinanceTechCompaniesDiscussion
Search
Sign inJoin
goglidesgoglides.devSocial learning for Finance and Tech.
TermsPrivacyDisclaimerModerationAcceptable UseDMCAContact
Company / Finance

QuidelOrtho Corporation

QDEL · NASDAQ

QuidelOrtho reported FY2025 revenue of $2.73 billion and 2026 Q1 revenue of $619.8 million. The thesis turns on diagnostics demand, integration execution, operating losses, cash conversion and balance-sheet repair.

FollowAdd to WatchlistAsk Question
NASDAQQDELCoverage BootstrapQuidelOrtho Corporation
OverviewFinancialsResearchTimelineCompareValuationScorecardDiscussion
Latest ReportMay 20, 2026QuidelOrtho: diagnostics scale still has to repair the profit signalView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 of 1 reports match
Clear filters
Selected tags
Coverage BootstrapNasdaq
Clear tags
MatchAny tagAll tags
Latest Thesis

QuidelOrtho: diagnostics scale still has to repair the profit signal

QuidelOrtho reported FY2025 revenue of $2.73 billion and 2026 Q1 revenue of $619.8 million. The thesis turns on diagnostics demand, integration execution, operating losses, cash conversion and balance-sheet repair.

May 20, 2026Research reportSlides available
Read reportOpen slidesDiscussion (0)
QuidelOrtho Corporationdiagnostics scale still has to repair the profit signalMay 20, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
QuidelOrtho: diagnostics scale still has to repair the profit signalQuidelOrtho reported FY2025 revenue of $2.73 billion and 2026 Q1 revenue of $619.8 million. The thesis turns on diagnostics demand, integration execution, operating losses, cash conversion and balance-sheet repair.NASDAQMay 20, 2026Research reportReadSlides

Report Sources

No source records are attached to the current company reports.